FDA Steps Up Efforts To Prevent Non-compliant Investigators And Others From Participating In New Product Development

Published: Aug 10, 2009

Bookmark and Share

Medical News Today -- The U.S. Food and Drug Administration today announced it has stepped up its efforts to prevent non-compliant investigators and others from participating in new product development. The FDA's procedures for debarment and disqualification have been enhanced to better protect participants in clinical studies and for ensuring the safety and effectiveness of the medical products marketed to the American public.

Back to news